Biomarin Pharmaceutical (BM8.F) Q3 2019 Earnings

1AugConfirmed
Q4 2018
Q1 2019
Q2 2019
Q3 2019
-0.29
-0.2
-0.11
-0.02

Details

Expected EPS
-0.10834200000000001
Actual EPS
-0.1895985
Surprise EPS
-0.08
Surprise Percent
+75%

Description

Biomarin Pharmaceutical (BM8.F) has reported earnings of -0.1895985 per share for Q3 2019.

0 Comments

Share your thoughts